GenEndeavor

Executive Summary

GenEndeavor is a private diagnostics company based in San Diego, founded in 2018, dedicated to enabling very early screening of genetic and infectious diseases. The company's core mission is to lower the detection limit of rare mutations and pathogens, allowing diseases to be identified while they are still treatable. By developing sensitive, rapid, and affordable point-of-care assay technology platforms, GenEndeavor aims to shift the diagnostic paradigm from reactive to proactive medicine. While still in an early stage with limited public financial or operational data, the company's platform holds significant promise for addressing unmet needs in early disease detection, particularly in resource-limited settings where access to timely diagnostics is critical.

Upcoming Catalysts (preview)

• Q2 2026Series A Funding Round65% success
• Q4 2026Clinical Validation Study Results40% success
• Q3 2026Strategic Partnership with a Major Health System50% success